<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="25523">Nicotinamide adenine dinucleotide phosphate</z:chebi> oxidase (NOX) is widely expressed in brain tissue including neurons, glia, and endothelia in neurovascular units </plain></SENT>
<SENT sid="1" pm="."><plain>It is a major source of oxidants in the post-ischemic brain and significantly contributes to ischemic brain damage </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> occurs after <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> and is known to be associated with post-ischemic <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Post-ischemic <z:mp ids='MP_0001845'>inflammation</z:mp> also causes progressive brain injury </plain></SENT>
<SENT sid="4" pm="."><plain>In this study we investigated the role of NOX2 in post-ischemic cerebral <z:mp ids='MP_0001845'>inflammation</z:mp> using a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model in mice </plain></SENT>
<SENT sid="5" pm="."><plain>We demonstrate that mice with NOX2 subunit gp91(phox) knockout (gp91 KO) showed 35-44% less <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> at 1 and 3 days of reperfusion compared with <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) mice </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="1" ids="50694">Minocycline</z:chebi> further reduced brain damage in the gp91 KO mice at 3 days of reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>The gp91 KO mice exhibited less severe post-ischemic <z:mp ids='MP_0001845'>inflammation</z:mp> in the brain, as evidenced by reduced microglial activation and decreased upregulation of <z:mp ids='MP_0001845'>inflammation</z:mp> mediators, including interleukin-1β (IL-1β), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-α, inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthases, CC-chemokine ligand 2, and CC-chemokine ligand 3 </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, we demonstrated that an intraventricular injection of IL-1β enhanced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>- and reperfusion-mediated brain damage in the WT mice (double the infarction volume), whereas, it failed to aggravate <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> in the gp91 KO mice </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, these results demonstrate the involvement of NOX2 in post-ischemic neuroinflammation and that NOX2 inhibition provides neuroprotection against inflammatory cytokine-mediated brain damage </plain></SENT>
</text></document>